Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Baxter has become aware that the vial-mate vial reconstitution device is not fully effective when used with i.V. bags that do not contain a minimum amount of air. the viaflex bags currently marketed in canada are not injected with air during production and may not contain this minimum amount of air. therefore incomplete reconstitution may result when the vial-mate device is used with the viaflex bags.